Table 5 Resistance among S. aureus from BSI

Methicillin (MRSA)

40/108 (37%)

12/38 (31.6%)

12/31 (38.7%)

0/7 (0%)

0.074

Erythromycin

39/72 (54.2%)

11/23 (47.8%)

10/18 (55.6%)

1/5 (20%)

0.317

Clindamycin

56/109 (51.4%)

21/40 (52.5%)

18/23 (54.5%)

3/7 (42.9%)

0.689

Chloramphenicol

35/105 (33.3%)

14/38 (36.8%)

11/31 (35.5%)

3/7 (42.9%)

1

Gentamicin

18/76 (23.7%)

9/26 (34.6%)

7/21 (33.3%)

2/5 (40%)

1

Ciprofloxacin

19/99 (19.2%)

7/33 (21.2%)

6/28 (21.4%)

1/5(20%)

1

Levofloxacin

18/103 (17.5%)

9/40 (22.5%)

6/13 (18.2%)

3/7 (42.9%)

0.316

Co-trimoxazole

8/62 (12.9%)

5/28(17.9%)

4/21 (19%)

1/7 (14.3%)

1

Rifampicin

10/95 (10.5%)

6/33 (18.2%)

5/27 (18.5%)

1/6 (16.7%)

1

Vancomycin^b

0/63 (0%)

-

-

-

-